EYENational Vision Holdings, Inc.
The Read
8% after Q1 2026 despite beats as management flagged macro, weather, and website replatforming headwinds.
The schedule
- Tue20Oct
Under President Trump's administration, the broader retail and eyewear sector faces strict tariff scrutiny, raising material supply chain risks for National Vision's imported frames.
- Sun20Dec
Year-end flexible spending account (FSA) flushes traditionally drive a seasonal volume surge in prescription eyewear and contact lenses.
- Tue9Feb
Full-year results and FY2027 guidance will benchmark National Vision's store expansion pace and structural profitability.
- Mon10May
The Q1 2027 earnings release will measure early-year momentum and the ongoing success of National Vision's remote exam footprint.
- Mon9Aug
Past
- Tue15Sep
A strategic update on the deployment of remote eye exams and digital platforms, aiming to reduce optometric staffing bottlenecks and expand margins.
- Sun9Aug
National Vision is scheduled to report Q2 2026 earnings, with focus heavily skewed toward its $692M debt load and whether operating margins can rebound after the Q1 sell-off.
- Sat20Jun
Actual outcome: Bull · $18.86 at outcome
The stock surged past the $17.50 bull target following the announcement of a strategic partnership with SportifEye Optics to produce and commercialize SpectraGuard Lenses in the United States. This expansion of the company's lab partnership network into sport, safety, and performance eyewear provided a strong growth catalyst, overriding prior market concerns about specialty retail consumer weakness and margin risks.
With shares trading near $15.44 and RSI deeply oversold at 29, the market has aggressively priced in specialty retail consumer weakness.
- Wed3Jun
Actual outcome: Bull · $15.44 at outcome
National Vision reported in-line Q3 EPS of $0.39, meeting market expectations. While the stock experienced a minor pullback immediately following the report, it easily exceeded the bull target and continued to climb over the following month. The broader upward momentum was driven by investor optimism around the company's strategic focus on smart-glasses expansion, premium upgrades, and military growth to boost ticket sizes and margin gains.
Anchoring off $12.80, Q3 earnings will serve as a definitive health check ahead of the critical holiday season.
- Thu14May
Actual outcome: Bear · $17.13 at outcome
National Vision reported Q1 results that beat headline EPS and revenue estimates, highlighted by a 4.5% rise in comparable sales and expanded operating margins. However, the stock hit a 52-week low and fell well below the bear floor as management acknowledged ongoing headwinds from macroeconomic volatility, weather, and a website replatforming early in the second quarter. Despite reiterating full-year guidance, these pressures overshadowed the Q1 beat and drove a sustained sell-off.
EYE will report Q1 results amidst rising consumer discretionary spending pressures.
- Wed4Mar
Actual outcome: Bear · $26.93 at outcome
National Vision met Q4 EPS estimates exactly at $0.04 per share, but the stock fell 7.3% following the earnings release and FY2026 guidance. After a massive 129% rally over the previous year driven by store growth and margin expansion, the lack of a significant earnings beat or upside guidance prompted investors to take profits. The downward momentum continued significantly in the following months, reflecting a broader cooling of sentiment after the stock's extended run.
Release of full-year 2025 results and critical initial guidance for 2026. Market focus on margin expansion and comparable store sales growth. A strong beat could re-rate the stock, moving it past key technical resistance.